245 related articles for article (PubMed ID: 15781060)
1. Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice.
Baker SA; Stanford LE; Brown RE; Hagg T
Brain Res; 2005 Mar; 1039(1-2):177-88. PubMed ID: 15781060
[TBL] [Abstract][Full Text] [Related]
2. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
Ostergaard K; Jones SA; Hyman C; Zimmer J
Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
4. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
Canudas AM; Pezzi S; Canals JM; Pallàs M; Alberch J
Brain Res Mol Brain Res; 2005 Mar; 134(1):147-54. PubMed ID: 15790538
[TBL] [Abstract][Full Text] [Related]
5. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice.
Zechel S; Jarosik J; Kiprianova I; Schober A; Unsicker K; von Bohlen und Halbach O
Eur J Neurosci; 2006 Mar; 23(6):1671-5. PubMed ID: 16553632
[TBL] [Abstract][Full Text] [Related]
6. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
[TBL] [Abstract][Full Text] [Related]
7. Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.
von Bohlen und Halbach O; Minichiello L; Unsicker K
FASEB J; 2005 Oct; 19(12):1740-2. PubMed ID: 16037097
[TBL] [Abstract][Full Text] [Related]
8. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice.
Zaman V; Nelson ME; Gerhardt GA; Rohrer B
Exp Neurol; 2004 Dec; 190(2):337-46. PubMed ID: 15530873
[TBL] [Abstract][Full Text] [Related]
10. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
[TBL] [Abstract][Full Text] [Related]
11. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
[TBL] [Abstract][Full Text] [Related]
12. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice.
Dluzen DE; Story GM; Xu K; Kucera J; Walro JM
Exp Neurol; 1999 Dec; 160(2):500-7. PubMed ID: 10619567
[TBL] [Abstract][Full Text] [Related]
13. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopamine output is compromised within +/- BDNF mice.
Dluzen DE; Anderson LI; McDermott JL; Kucera J; Walro JM
Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489
[TBL] [Abstract][Full Text] [Related]
15. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo.
Ward NL; Hagg T
Exp Neurol; 2000 Apr; 162(2):297-310. PubMed ID: 10739636
[TBL] [Abstract][Full Text] [Related]
16. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice.
Dluzen DE; Gao X; Story GM; Anderson LI; Kucera J; Walro JM
Exp Neurol; 2001 Jul; 170(1):121-8. PubMed ID: 11421589
[TBL] [Abstract][Full Text] [Related]
18. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice.
Küppers E; Krust A; Chambon P; Beyer C
Psychoneuroendocrinology; 2008 Jul; 33(6):832-8. PubMed ID: 18472350
[TBL] [Abstract][Full Text] [Related]
19. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.
Hyman C; Hofer M; Barde YA; Juhasz M; Yancopoulos GD; Squinto SP; Lindsay RM
Nature; 1991 Mar; 350(6315):230-2. PubMed ID: 2005978
[TBL] [Abstract][Full Text] [Related]
20. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.
Papanikolaou T; Amano T; Lennington J; Sink K; Farrar AM; Salamone J; Yang X; Conover JC
Eur J Neurosci; 2009 Jun; 29(12):2264-75. PubMed ID: 19508691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
